Dialysis Corporation of America (DCAI) Amends Revolving Credit Facility with KeyBank

November 5, 2008 1:29 PM EST

Dialysis Corporation of America (Nasdaq: DCAI) has amended its secured revolving credit facility with KeyBank (NYSE: KEY) to provide for up to $25,000,000 in financing. The three-year agreement provides for both base rate and LIBOR loans with interest rates to be based, respectively, upon either the bank's base rate or the London InterBank Offered Rate (LIBOR), plus an applicable margin.

The company plans to use its new credit facility to support its continued rapid growth and for general business purposes.

Dialysis Corporation of America develops and operates outpatient kidney dialysis centers that provide dialysis and ancillary services to patients suffering from chronic kidney failure, generally referred to as end stage renal disease (ESRD). [SM]


Related Categories

Corporate News

Stocks Mentioned

DCAI 6.80

+0.00 +0.00%
Volume: 1,126
Track DCAI

KEY 8.03

+0.08 +1.01%
Volume: 4,277,112
Track KEY


Related Entities


Add Your Comment